Israel21c is reporting that an Ashkelon, Israel based company Integrity Applications has developed a noninvasive glucometer that “combines three independent technologies that are operated simultaneously to provide an accurate and reliable on-the-spot reading of glucose levels in the blood. The technologies include ultrasound, conductivity, and heat capacity.” Also according to the article, the Phase 2 clinical trials of the device are to begin in Israel, the US and Spain in the next couple of months. The device illustrated above is a future version of the product, below is an existing prototype.
The company is still hush-hush about its technology. But here’s what’s known. The device measures glucose levels via an ear clip. The device needs to be recalibrated only once a month and can support up to 3 users, each with an individual earring unit.
From the company:
The device is battery operated and includes 2 subunits: Main Unit, containing Display and Control, Transmitter, Receiver and Processor, and “Earring” unit, containing Sensors and Calibration Electronics, to be attached (externally clipped) to the earlobe, so that the monitoring is done non-invasively.
GlucoTrack™’s principle of operation is based on simultaneous measurement of three independent parameters, by using three different technologies: ultrasound, conductivity and heat capacity. IR technology, commonly used by other developers, causes problem of data analysis, due to physiological characteristics; therefore it is not used by GlucoTrack™. The measurements’ results are analyzed by a particular algorithm, and the combined end-result is displayed to the user on a digital screen. Extreme values, pre determined by a user, cause visual and audible alerts.